LGHT Price Forecast & ETF Analysis. Dividend · Expense Ratio · Holdings · NAV · RSI · MACD | US Stocks Today
Full metrics table
| Category | Global or ExUS Equities - Industry Sector | Expense | 0.85% | Return% 1Y | 7.31% | Total Holdings | 30 | Perf Week | 1.37% | Volume | 38,855 |
| Asset Type | Equities (Stocks) | AUM | $3M | Return% 3Y | - | NAV | $11.14 | Perf Month | 6.74% | Avg Volume | 0.00M |
| ETF Type | Global Equities | Dividend TTM | - | Return% 5Y | - | 52W High | -2.79% | Perf Quarter | 32.87% | Rel Volume | 10.32 |
| Active/Passive | Active | Div Gr. 3/5Y | - | Return% 10Y | - | 52W Low | 40.22% | Perf Half Y | 29.09% | Prev Close | $11.14 |
| IPO | 2024/1/10 | Flows% 1M | 0% | Return% SI | 3.3% | RSI (14) | 62.63 | Perf YTD | 11.35% | Price | $11.13 |
| Beta | 0.59 | Flows% 3M | -3.26% | Flows% YTD | -36.11% | Flows% 1Y | -37.67% | Perf Year | 4.5% | Volatility(W/M) | 1.98% 1.85% |
| SMA20 | 3.25% | SMA50 | 7.72% | SMA200 | 19.93% | ATR | 0.23 | ||||
Langar Global Healthtech ETF seeks long-term growth of capital. Under normal circumstances, the fund will invest at least 80% of the fund's net assets (plus borrowings for investment purposes) in U.S. and foreign exchange-listed equity securities of healthcare technology companies and American Depository Receipts ("ADRs") on those securities. These securities may be of any market capitalization. The fund is non-diversified.
The top 10 make up 73% of the fund
Concentrated in a few names. When they swing, the ETF swings with them.
Largest sectors first.
Over the past 1 year, on the higher side
3% below its 1-year high.
Traded more than usual. That is 1032% of its average volume.
Long-term returns are roughly flat
Tap to view numbers
The price swings a lot
At its worst (January 2025) it fell 29% and took 153 days to recover.
Tap to view numbers
No dividend
There is no profit to distribute yet.
A lot of money is flowing out
Over the past year, money equal to 37.7% of assets left.
Tap to view numbers